Compound information
- Natural Products
- ZC1776905
- Molecular Formula
- C18H21ClN4O
- Molecular Weight
- 344.140388972 g/mol
- Structure
-
- IUPAC Name
- N-(5-chloro-2-methyl-phenyl)-4-(3-pyridylmethyl)piperazine-1-carboxamide
- InChI
- InChI=1S/C18H21ClN4O/c1-14-4-5-16(19)11-17(14)21-18(24)23-9-7-22(8-10-23)13-15-3-2-6-20-12-15/h2-6,11-12H,7-10,13H2,1H3,(H,21,24)
- InChI Key
- TUTKNFJFMCXBQG-UHFFFAOYSA-N
- SMILES
- Cc1ccc(Cl)cc1NC(=O)N1CCN(Cc2cccnc2)CC1
- Source
- ZINC000013325075
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 48.47 Å2 | LogP | 2.637 |
LogS | -2.686 | LogD | 2.985 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.808 | Pgp substrate | 0.834 |
HIA | 0.966 | F20 % | 0.989 |
F30 % | 0.976 | Caco-2 | -4.73 |
MDCK | -4.892 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.761 | PPB | 91.763 |
VD | 1.086 | Fu | 0.613 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.15 | CYP1A2 substrate | 0.81 |
CYP2A6 substrate | 0.866 | CYP2B6 substrate | 0.784 |
CYP2C19 inhibitor | 0.783 | CYP2C19 substrate | 0.909 |
CYP2C8 substrate | 0.912 | CYP2C9 inhibitor | 0.679 |
CYP2C9 substrate | 0.969 | CYP2D6 inhibitor | 0.985 |
CYP2D6 substrate | 0.998 | CYP2E1 substrate | 0.905 |
CYP3A4 inhibitor | 0.745 | CYP3A4 substrate | 0.991 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.46 | CL | 10.57 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.154 | Hepatotoxicity | 0.72 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.893 |
FDAMDD | 0.436 | Skin Sensitization | 0.907 |
Carcinogenicity | 0.133 | Eye Corrosion | 0.002 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.891 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.619 | IGC50 | 2.569 |
LC50FM | 2.531 | LC50DM | -1.333 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.322 | NR-AR-LBD | 0.193 |
NR-AhR | 0.732 | NR-Aromatase | 0.033 |
NR-ER | 0.33 | NR-ER-LBD | 0.292 |
NR-PPAR-gamma | 0.157 | SR-ARE | 0.859 |
SR-ATAD5 | 0.317 | SR-HSE | 0.185 |
SR-MMP | 0.016 | SR-p53 | 0.053 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.